Author:
Jenkins Suzanne,Yang James C-H.,Ramalingam Suresh S.,Yu Karen,Patel Sabina,Weston Susie,Hodge Rachel,Cantarini Mireille,Jänne Pasi A.,Mitsudomi Tetsuya,Goss Glenwood D.
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference36 articles.
1. Metastatic non-small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Novello;Ann Oncol,2016
2. NCCN Clinical Practice Guidelines in Oncology. Non–small cell lung cancer, Version 5. 2017. https://www.nccn.org/store/login/login.aspx?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf. Accessed April 1, 2017.
3. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR;Maemondo;N Engl J Med,2010
4. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial;Mitsudomi;Lancet Oncol,2010
5. First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study;Wu;Ann Oncol,2015
Cited by
235 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献